GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug QLS5316 enters first human tests for advanced cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called QLS5316 in about 300 people with advanced solid tumors (including colorectal, stomach, head and neck, and lung cancers) who have no other standard treatment options. The main goals are to check the drug's safety, find the right dose,…
Matched conditions: GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 08:25 UTC
-
New pill combo aims to slow stomach cancer after first treatment fails
Disease control Not yet recruitingThis study tests whether a combination of an oral chemotherapy (paclitaxel solution) and a targeted drug (fruquintinib) can help control advanced stomach or gastroesophageal junction cancer after the first treatment stops working. About 150 adults whose cancer has worsened after …
Matched conditions: GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC